IP Library Patent Application 12225123
Patent Application
App. No. 12/225,123

Method For Preparing Indene Derivatives, And Intermediates For Preparation Of Derivatives

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/225,123
Abstract

Indene derivatives that are utilizable as intermediates in the synthesis of the vitamin D 2 derivative paricalcitol, which is useful as pharmaceutical are efficiently prepared by subjecting a vitamin D 2 derivative such as 25-hydroxyvitamin D 2 to a two-steps oxidation reaction using an oxidizing agent such as potassium permanganates and sodium periodate in a suitable solvent such as methanol and ethanol.

Claims (31)

1 : A method of preparing an indene derivative denoted by formula (III)

(in formula (III), R 1 denotes a hydrogen atom or a protective group for a hydroxyl group), characterized by comprising oxidizing a vitamin D 2 derivative denoted by formula (V)

(in formula (V), both X 1 and X 2 denote hydroxyl groups or jointly form an epoxy group, and each of R 1 and R 2 independently denotes a hydrogen atom or a protective group for a hydroxyl group).

2 : The preparing method in accordance with claim 1 , wherein the oxidation of the vitamin D 2 derivative denoted by formula (V) is conducted in solvent with an oxidizing agent.

3 : The preparing method in accordance with claim 1 , wherein the protective groups for hydroxyl groups denoted by R 1 and R 2 are silyl groups, alkoxymethyl groups, aralkyloxymethyl groups, or acyl groups.

4 : The preparing method in accordance with claim 1 , wherein the protective groups for hydroxyl groups denoted by R 1 and R 2 are trimethylsilyl groups, triethylsilyl groups, methoxymethyl groups, benzyloxymethyl groups, or acetyl groups.

5 . The preparing method in accordance with claim 1 , wherein the vitamin D 2 derivative denoted by formula (V) is 7,8,25-trihydroxyvitamin D 2 denoted by formula (II)

6 : The preparing method in accordance with claim 1 , wherein the vitamin D 2 derivative denoted by formula (V) is prepared by oxidizing the vitamin D 2 derivative denoted by formula (IV)

(in formula (IV), both R 1 and R 2 are defined as in formula (V))

7 : The preparing method in accordance with claim 6 , wherein the oxidation of the vitamin D 2 derivative denoted by formula (IV) is conducted in solvent with an oxidizing agent.

8 : The preparing method in accordance with claim 5 , wherein the 7,8,25-trihydroxyvitamin D 2 denoted by formula (II) is prepared by oxidizing the 25-hydroxyvitamin D 2 denoted by formula (I)

9 : A method of preparing a vitamin D 2 derivative denoted by formula (V)

(where in formula (V), both X 1 and X 2 denote hydroxyl groups or jointly form an epoxy group, and each of R 1 and R 2 independently denotes a hydrogen atom or a protective group for a hydroxyl group), characterized by comprising the step of oxidizing the vitamin D 2 derivative denoted by formula (IV)

(in formula (IV), both R 1 and R 2 are defined as in formula (V))

10 : The preparing method in accordance with claim 9 , wherein the oxidation of the vitamin D 2 derivative denoted by formula (IV) is conducted in solvent with an oxidizing agent.

11 : The preparing method in accordance with claim 9 , wherein the protective groups for hydroxyl groups denoted by R 1 and R 2 are silyl groups, alkoxymethyl groups, aralkyloxymethyl groups, or acyl groups.

12 : The preparing method in accordance with claim 9 , wherein the protective groups for hydroxyl groups denoted by R 1 and R 2 are trimethylsilyl groups, triethylsilyl groups, methoxymethyl groups, benzyloxymethyl groups, or acetyl groups.

13 : The preparing method in accordance with claim 9 , wherein the vitamin D 2 derivative denoted by formula (V) is the 7,8,25-trihydroxyvitamin D 2 denoted by formula (II)

and the vitamin D 2 derivative denoted by formula (IV) is the 25-hydroxyvitamin D 2 denoted by formula (I)

14 : A vitamin D 2 derivative denoted by formula (V)

(in formula (V), both X 1 and X 2 denote hydroxyl groups or jointly form an epoxy group and each of R 1 and R 2 independently denotes a hydrogen atom or a protective group for a hydroxyl group).

15 : The derivative in accordance with claim 14 , wherein the protective groups for hydroxyl groups denoted by R 1 and R 2 are silyl groups, alkoxymethyl groups, aralkyloxymethyl groups, or acyl groups.

16 : The derivative in accordance with claim 14 , wherein the protective groups for hydroxyl groups denoted by R 1 and R 2 are trimethylsilyl groups, triethylsilyl groups, methoxymethyl groups, benzyloxymethyl groups, or acetyl groups.

17 : The derivative in accordance with claim 14 , wherein R 1 and R 2 denote hydrogen atoms.

18 : The derivative in accordance with claim 14 , wherein X 1 and X 2 both denote hydroxyl groups and R 1 and R 2 denote hydrogen atoms.

19 : A method of preparing an indene derivative denoted by formula (III)

(in formula (III), R 1 denotes a hydrogen atom or a protective group for a hydroxyl group), characterized by comprising oxidizing the vitamin D 2 derivative denoted by formula (IV)

(where in formula (IV), each of R 1 and R 2 independently denotes a hydrogen atom or a protective group for a hydroxyl group).

20 : The preparing method in accordance with claim 19 , wherein the oxidation of the vitamin D 2 derivative denoted by formula (IV) is conducted in solvent with an oxidizing agent.

21 : The preparing method in accordance with claim 19 , wherein the protective groups for the hydroxyl groups denoted by R 1 and R 2 are silyl groups, alkoxymethyl groups, aralkyloxymethyl groups, or acyl groups.

22 : The preparing method in accordance with claim 19 , wherein the protective groups for the hydroxyl groups denoted by R 1 and R 2 are trimethylsilyl groups, triethylsilyl groups, methoxymethyl groups, benzyloxymethyl groups, or acetyl groups.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2012
From: MERCIAN CORPORATION
To: MICROBIOPHARM JAPAN CO., LTD.
Reel/Frame 027499/0035 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2009
From: TOYODA, ASAKO; NAGAI, HAZUKI
To: MERCIAN CORPORATION
Reel/Frame 022293/0141 →